Trial Profile
Multicenter, Double-Blind, Randomized, Parallel Group Study on Efficacy and Safety of Enteric-Coated Mycophenolate Sodium vs. Mycophenolate Mofetil in de Novo Chinese Renal Transplant Recipients
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 24 Apr 2013
Price :
$35
*
At a glance
- Drugs Mycophenolate sodium (Primary) ; Mycophenolate mofetil
- Indications Renal transplant rejection
- Focus Therapeutic Use
- Sponsors Novartis
- 10 Jan 2008 The expected completion date for this trial is now 1 Jan 2006.
- 07 Jan 2008 Status change from in progress to completed.
- 27 Jan 2007 Status changed from recruiting to in progress